Modification of Complications in Infertile Men with Varicocele by Curcumin Nanomicels
Not Applicable
Recruiting
- Conditions
- Varicocele.Scrotal varicesI86.1
- Registration Number
- IRCT20170923036334N3
- Lead Sponsor
- Iranian academic center for education culture and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Infertile Men with Varicocele
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Levels of Sex Hormones. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Eliza Kit.;Sperm Parameters. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Standard Clinical Analysis of Semen for Evaluation of Sperm Parameters with The Usual Laboratory Method and Light Microscope According to the Organization CriteriaWHO-2010 World Health Takes Place.;Oxidative Stress Rate. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: ROS Positive Sperms were Evaluated Using H2DCFDA (DCFH - DA: 2 ', 7'-dichlorodihydrofluoresceindiacetat) (Sigma Co., USA) and Analyzed by Flow Cytometry.
- Secondary Outcome Measures
Name Time Method Viability. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Viability is Assessed by Eosin-Nigrosin Staining and Examined Using a Light Microscope.;DNA Damage Assessment. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Tunnel Kit.;Measurement of Sperm Mitochondrial Activity. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Rhodamine Staining is Used to Assess the Mitochondrial Activity of Sperm.